Takeda executive granted 49,558 ADS RSU award

Platford Giles Richard reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Platford Giles Richard reported acquisition or exercise transactions in this Form 4 filing.

Takeda Pharmaceutical reported that President, IBU, Giles Richard Platford received an equity award in the form of 49,558 American Depositary Shares. The award was granted at no cash cost to him as a compensation-related grant.

The award is structured as restricted stock units, with each RSU representing a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027. After this grant, Platford directly holds 346,921 American Depositary Shares.

Insider Trade Summary

Grant/Award: 49,558 shares

Grant/Award 1 txn

Insider Platford Giles Richard

Role President, IBU

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares	49,558	$0.00	$0.00

Holdings After Transaction: American Depositary Shares — 346,921 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Key Figures

RSU grant size: 49,558 American Depositary Shares Grant price: $0.0000 per share Holdings after transaction: 346,921 American Depositary Shares +2 more

5 metrics

RSU grant size 49,558 American Depositary Shares Equity award to President, IBU on July 1, 2026

Grant price $0.0000 per share Indicates compensation grant, not market purchase

Holdings after transaction 346,921 American Depositary Shares Direct ownership following RSU grant

Vesting start date July 1, 2027 First of three equal annual RSU vesting installments

Number of vesting installments 3 annual installments RSUs vest in three equal annual tranches

Key Terms

restricted stock units (RSUs), American Depositary Shares, contingent right, vesting

4 terms

restricted stock units (RSUs) financial

"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

American Depositary Shares financial

"Each RSU represents a contingent right to receive one American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

contingent right financial

"Each RSU represents a contingent right to receive one American Depositary Share."

vesting financial

"The RSUs vest in three equal annual installments beginning on July 1, 2027."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What insider transaction did Takeda (TAK) report for Giles Richard Platford?

Takeda reported that Giles Richard Platford, President of its IBU, received a grant of 49,558 American Depositary Shares as an equity award. These shares were granted at no cash price as part of his compensation and increase his direct holdings.

How many Takeda (TAK) American Depositary Shares were granted in this Form 4?

The filing shows a grant of 49,558 American Depositary Shares to Giles Richard Platford. This award was recorded with a price per share of 0.0000, indicating a compensation grant rather than an open-market purchase transaction.

How many Takeda (TAK) shares does Giles Richard Platford hold after this award?

Following the reported transaction, Giles Richard Platford directly holds 346,921 American Depositary Shares of Takeda. This total includes the newly granted award and reflects his direct ownership position after the equity grant recorded in the Form 4.

What type of equity award did Takeda (TAK) grant to Giles Richard Platford?

The award consists of restricted stock units (RSUs), each representing a contingent right to receive one American Depositary Share. This means the actual shares are delivered over time as vesting conditions are met rather than immediately at the grant date.

What is the vesting schedule for the Takeda (TAK) RSUs granted in this filing?

The RSUs vest in three equal annual installments beginning on July 1, 2027. Each year, one-third of the 49,558 units becomes deliverable as American Depositary Shares, provided the vesting conditions described apply and are satisfied over that schedule.

Did Giles Richard Platford buy or sell Takeda (TAK) shares on the market in this Form 4?

The filing reports a grant or award acquisition, not a market trade. Shares were acquired at a reported price of 0.0000 per share as part of a restricted stock unit compensation package, rather than through an open-market purchase or sale transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Platford Giles Richard

(Last) (First) (Middle)

650 E. KENDALL STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, IBU

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	07/01/2026		A(1)		49,558	A	$0	346,921	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Remarks:

	/s/ Kate Huleatt, by power of attorney, for Giles R. Platford	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)